Clinical Trials Logo

Encephalitis clinical trials

View clinical trials related to Encephalitis.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT05639504 Withdrawn - Sepsis Clinical Trials

Sepsis Prognosis and Diagnosis in the Emergency Department (SPEED)

Start date: December 2022
Phase:
Study type: Observational

This study aims to evaluate the diagnostic and prognostic performance of a novel mRNA diagnostic/prognostic classifier (interprets the expression of 29 host response mRNA biomarkers) from whole blood in adult patients presenting to emergency departments (ED) with suspected infection.

NCT ID: NCT04371003 Withdrawn - Oxidative Stress Clinical Trials

Prospective Investigation of Oxidative Stress in West Nile Virus Infection

PROWENI
Start date: September 1, 2020
Phase:
Study type: Observational

The investigator hypothesizes that oxidative stress responses to West Nile virus infection in the central nervous system determine the severity of infection and the long-term neurological, neuropsychological and functional sequelae of West Nile Neuroinvasive Disease.

NCT ID: NCT04344626 Withdrawn - Stroke Clinical Trials

Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery

Start date: July 16, 2018
Phase: N/A
Study type: Interventional

Refractory epilepsy, meaning epilepsy that no longer responds to medication, is a common neurosurgical indication in children. In such cases, surgery is the treatment of choice. Complete resection of affected brain tissue is associated with highest probability of seizure freedom. However, epileptogenic brain tissue is visually identical to normal brain tissue, complicating complete resection. Modern investigative methods are of limited use. An important subjective assessment during surgery is that affected brain tissue feels stiffer, however there is presently no way to determine this without committing to resecting the affected area. It is hypothesized that intra-operative use of a tonometer (Diaton) will identify abnormal brain tissue stiffness in affected brain relative to normal brain. This will help identify stiffer brain regions without having to resect them. The objective is to determine if intra-operative use of a tonometer to measure brain tissue stiffness will offer additional precision in identifying epileptogenic lesions. In participants with refractory epilepsy, various locations on the cerebral cortex will be identified using standard pre-operative investigations like magnetic resonance imagin (MRI) and positron emission tomography (PET). These are areas of presumed normal and abnormal brain where the tonometer will be used during surgery to measure brain tissue stiffness. Brain tissue stiffness measurements will then be compared with results of routine pre-operative and intra-operative tests. Such comparisons will help determine if and to what extent intra-operative brain tissue stiffness measurements correlate with other tests and help identify epileptogenic brain tissue. 24 participants have already undergone intra-operative brain tonometry. Results in these participants are encouraging: abnormally high brain tissue stiffness measurements have consistently been identified and significantly associated with abnormal brain tissue. If the tonometer adequately identifies epileptogenic brain tissue through brain tissue stiffness measurements, it is possible that resection of identified tissue could lead to better post-operative outcomes, lowering seizure recurrences and neurological deficits.

NCT ID: NCT03004209 Withdrawn - Clinical trials for Autoimmune Encephalitis

Effect of Erythropoietin in Refractory Autoimmune Encephalitis Patients

Start date: December 2016
Phase: Phase 4
Study type: Interventional

This study evaluates the efficacy of erythropoietin in refractory autoimmune encephalitis. Ten patients will receive 100 IU/kg of erythropoietin 3 times a week for 12 weeks.

NCT ID: NCT03003143 Withdrawn - Clinical trials for Autoimmune Encephalopathy

Effect of Vigabatrin in Refractory Autoimmune Encephalitis Patients

Start date: November 2016
Phase: N/A
Study type: Interventional

Investigation of efficacy of vigabatrin in refractory autoimmune encephalitis patients

NCT ID: NCT01559831 Withdrawn - Clinical trials for Japanese Encephalitis

Immune Response in IXIARO Batch JEV09L37 Recipients Before and After Revaccination

Start date: June 2012
Phase: Phase 1
Study type: Interventional

IC51-319 is a single-arm, open-label study that investigates immune responses in subjects undergoing revaccination after receiving the subpotent batch of IXIARO JEV09L37 during primary immunization.

NCT ID: NCT00109304 Withdrawn - Clinical trials for Venezuelan Equine Encephalitis

Safety, Tolerability and Immunogenicity of the Venezuelan Equine Encephalitis (VEE) Attenuated Live-Virus Vaccine

Start date: July 2005
Phase: Phase 1
Study type: Interventional

This study is being done to determine the safety and tolerability of a new investigational vaccine referred to as VEE IA/B V3526, which may induce production of specific antibodies in vaccinated humans, and may protect them against infection with the Venezuelan Equine Encephalitis (VEE) Virus.